• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100139
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Device Issue (2379)
Patient Problems Hemorrhage/Bleeding (1888); Misdiagnosis (2159); Test Result (2695)
Event Date 04/04/2016
Event Type  Injury  
Manufacturer Narrative
Investigation conclusion: investigation pending.
 
Event Description
Report received of discrepant inratio values.Patient's therapeutic range 2-3.On (b)(6) 2016 inratio inr = 2.2.On (b)(6) 2016 lab inr = 16.On (b)(6) 2016 patient was admitted to (b)(6) medical center for bleeding from a pre-existing diabetic wound that was being treated; laboratory inr conducted upon admittance, lab inr=16.Following laboratory inr, coumadin was held for 3 days.Patient was also administered vitamin k and fluids for three days.Patient was not given any other medications/treatments.On (b)(6) 2016 patient was discharged from hospital with a lab inr = 6.5.Caller provided diagnosis as bleeding and critical inr.On (b)(6) 2016 inratio inr = 2.4.On (b)(6) 2016 inratio inr = 4.2 and lab inr = 4.9 (testing occurred simultaneously).Coumadin dose prior to (b)(6): 5 mg x3/week, 2.5 mg x4/week.Coumadin dose after (b)(6): 2.5 mg/day.
 
Manufacturer Narrative
Investigation/conclusion: the meter and strips associated with the complaint were returned for investigation.Returned strips tested on the returned meter met accuracy criteria.The customer's complaint was not replicated during in-house testing.Additionally, the returned meter met functional and thermistor testing requirements during investigation.A review of the manufacturing batch records for the reported strip lot did not uncover any non-conformances.The lot met release specifications.The customer was identified as having a condition that may impact the performance of the assay.This can not be ruled out as a cause for the observed discrepant results.Impedance curve analysis was not performed because the customers reported inr results were not present in the meter memory.Capa-(b)(4) was initiated to investigate the cause of highly discrepant results.Further investigation into this issue is being performed under capa-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key5677153
MDR Text Key45857469
Report Number2027969-2016-00399
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100139
Device Lot Number384911A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/05/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received06/10/2016
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-